June 18, 2026, 4:35 PM EDT A Food and Drug Administration advisory panel on Thursday recommended the approval of Moderna’s mRNA-based flu shot for older adults. If approved, it would be the world’s first messenger RNA flu shot, providing public health officials with a much more nimble tool to fight influenza. In a late-stage trial, the vaccine was found to be about 27% more effective than a standard flu shot.